Emory University’s NxStage Medical Inc. NXTM Stock Holding History

Emory University’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-71,954	Closed	-$1.8M	–	57
2017 Q2	$1.8M	Buy	+71,954	New	+$1.78M	1.59%	8

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Emory University's NXTM Position: Q3 2017 in Review

Emory University sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 71,954 shares — an estimated $1.8M sold.

Emory University first reported a position in NXTM in Q2 2017 and held it in 1 quarter. The position peaked at $1.8M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Emory University reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Emory University sold 71,954 NxStage Medical Inc. shares in Q3 2017, an estimated $1.8M.
Emory University first reported a position in NxStage Medical Inc. in Q2 2017 and held it in 1 quarter.
Emory University's NxStage Medical Inc. position peaked at $1.8M in Q2 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Emory University's 13F filing for Q3 2017, filed 14 Nov 2017.